PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 2, 2010, Pages

  Rodríguez Lagunas, M José ^a   Martín Venegas, Raquel ^a   Moreno, Juan José ^a   Ferrer, Ruth ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Arachidonic acid cascade; Eicosanoids; Intestine; Paracellular permeability; Tight junctions

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 6 [3 (4 CHLORO 2 METHYLPHENYLSULFONYLAMINOMETHYL)BICYCLO[2.2.2]OCTAN 2 YL] 5 HEXENOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; ACTIN; BUTAPROST; CALCIUM; CARBACYCLIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EP 1 RECEPTOR; EP 2 RECEPTOR; EP 3 RECEPTOR; EP 4 RECEPTOR; GR 63799; INOSITOL TRISPHOSPHATE; MANNITOL; MYOSIN LIGHT CHAIN KINASE; OCCLUDIN; ONO AE 248; ONO AE1 259; ONO AE3 208; ONO AE3 240; ONON AE1 329; PHOSPHOLIPASE C; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN ZO1; SULPROSTONE; UNCLASSIFIED DRUG; BICYCLO COMPOUND; HEXANOIC ACID DERIVATIVE; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTANOID RECEPTOR EP1;

ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENTERITIS; ENZYME ACTIVITY; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOLOCALIZATION; INFLAMMATION; MOLECULAR INTERACTION; MONOLAYER CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL DIFFERENTIATION; CELL STRAIN CACO 2; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BICYCLO COMPOUNDS; CACO-2 CELLS; CALCIUM; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; DINOPROSTONE; HEXANOIC ACIDS; HUMANS; INTESTINAL MUCOSA; RECEPTOR CROSS-TALK; RECEPTORS, PROSTAGLANDIN E;

EID: 77955885775     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00397.2009     Document Type: Article

References (54)

1. Abramovitz M, Adam M, Boie Y, Carrière M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, Metters KM. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483: 285-293, 2000.
2. Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability. J Immunol 180: 5653-5661, 2008.
3. 3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 197: 221-232, 2003.
4. Andreeva AY, Piontek J, Blasig IE, Utepbergenov DI. Assembly of tight junction is regulated by the antagonism of conventional and novel protein kinase C isoforms. Int J Biochem Cell Biol 38: 222-233, 2006. (Pubitemid 41619451)
5. Angulo J, Cuevas P, La Fuente JM, Pomerol JM, Ruiz-Castañé E, Puigvert A, Gabancho S, Fernández A, Ney P, Sáenz De Tejada I. Regulation of human penile smooth muscle tone by prostanoid receptors. Br J Pharmacol 136: 23-30, 2002. (Pubitemid 34499312)
6. Araki Y, Katoh T, Ogawa A, Bamba S, Andoh A, Koyama S, Fujiyama Y, Bamba T. Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radic Biol Med 39: 769-780, 2005. (Pubitemid 41149076)
7. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, Pamukcu R, Moore S, Lynch RG. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 123: 1527-1542, 2002. (Pubitemid 35231653)
8. Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 86: 191-201, 2006.
9. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 270: 18910-18916, 1995.
10. Boivin MA, Ye D, Kennedy JC, Al-Sadi R, Shepela C, Ma TY. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am J Physiol Gastrointest Liver Physiol 292: G590-G598, 2007. (Pubitemid 46263506)
11. 2+ signalling. J Biol Chem 277: 340-348, 2002.
12. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. Immunology 171: 6164-6172, 2003.
13. 2+ release activity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Biol Cell 99: 379-388, 2007.
14. 4 prostanoid receptor. Br J Pharmacol 130: 1919-1926, 2000.
15. 4 prostanoid receptors to induce IL-8 production in human colonic epithelial cell lines. Br J Pharmacol 156: 475-485, 2009.
16. 2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol 149: 611-623, 2006.
17. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273: 29745-29753, 1998.
18. 1 subtype. J Biol Chem 268: 26767-26772, 1993.
19. González-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-756, 2008.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
21. 2 in vagal sensory neurons: role of cAMP/PKA signaling pathway. J Neurophysiol 89: 1985-1993, 2003.
22. Hommes DW, Meenan J, de Haas M, ten Kate FJ, von dem Borne AE, Tytgat GN, van Deventer SJ. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. Gut 38: 564-567, 1996.
23. 4 suppresses colitis mucosal damage and CD4 cell activation in the gut. J Clin Invest 109: 883-893, 2002.
24. Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 27: 123-134, 2006.
25. Lawrence RA, Jones RL, Wilson NH. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Br J Pharmacol 105: 271-278, 1992.
26. 2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation. Am J Physiol Gastrointest Liver Physiol 293: G673-G681, 2007.
27. 2. BMC Cancer 8: 380, 2008. [The data are available at http://www.biomedcentral.com/ 1471-2407/8/380] [5 Feb, 2009].
28. Ma TY, Nguyen D, Bui V, Nguyen H, Hoa N. Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 276: G965-G974, 1999.
29. Ma TY, Tran D, Hoa N, Nguyen D, Merryfield M, Tarnawski A. Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc Res Tech 51: 156-168, 2000.
30. Martín-Venegas R, Roig-Pérez S, Ferrer R, Moreno JJ. Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation. J Lipid Res 47: 1416-1423, 2006.
31. 2 and upregulation of α2β1-integrin. Exp Cell Res 289: 342-351, 2003.
32. Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol 60: 121-142, 1998.
33. Namba T, Oida H, Sugimoto Y, Kakizuka A, Negishi M, Ichikawa A, Narumiya S. cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla. J Biol Chem 269: 9986-9992, 1994.
34. 2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist ONO-AE1-329. Scand J Immunol 56: 66-75, 2002.
35. Philpott DJ, McKay DM, Mak W, Perdue MH, Sherman PM. Signal transduction pathways involved in enterohemorrhagic Escherichia coliinduced alterations in T84 epithelial permeability. Infect Immun 66: 1680-1687, 1998.
36. Roig-Pérez S, Guardiola F, Moretó M, Ferrer R. Lipid peroxidation induced by DHA enrichment modifies paracellular permeability in Caco-2 cells: protective role of taurine. J Lipid Res 45: 1418-1428, 2004.
37. 2+ release from the endoplasmic reticulum in blowfly salivary glands. BMC Physiol 8: 10, 2008. http://www.biomedcentral.com/1472-6793/8/10 [5 Feb, 2009].
38. Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, Fu YX, Turner JR. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 132: 2383-2394, 2007.
39. Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther 19: 501-515, 2003.
40. 3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J Pharmacol Exp Ther 286: 1094-1102, 1998.
41. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119: 2095-2106, 2006.
42. Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22: 207-235, 2006.
43. 3 during colon cancer development. Gut 53: 1151-1158, 2004.
44. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 282: 11613-11617, 2007.
45. 2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cell. BMC Cell Biol 9: 63, 2008. http://www.biomedcentral.com/1471-2121/9/63 [5 Feb, 2009].
46. Tang TS, Tu H, Wang Z, Bezprozvanny I. Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase A and protein phosphatase 1α. J Neurosci 23: 403-415, 2003.
47. Turner JR, Angle JM, Black ED, Joyal JL, Sacks DB, Madara JL. PKC-dependent regulation of transepithelial resistance: roles of MLC and MLC kinase. Am J Physiol Cell Physiol 277: C554-C562, 1999.
48. + exchanger NHE3. Am J Physiol Cell Physiol 279: C1918-C1924, 2000.
49. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 169: 1901-1909, 2006.
50. Wagner LE, Joseph SK, Yule DI. Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation. J Physiol 586: 3577-3596, 2008.
51. Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, Yamamoto H, Maruyama T, Kondo K, Ushikubi F, Narumiya S, Sugimura T, Wakabayashi K. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res 59: 5093-5096, 1999.
52. 2 receptor antagonist. Biochem Pharmacol 50: 1731-1733, 1995.
53. Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 290: G496-G504, 2006.
54. 2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J Immunol 161: 3746-3752, 1999.